Supernus Pharmaceuticals (SUPN) Return on Capital Employed Growth (1y) (2013 - 2025)
Supernus Pharmaceuticals (SUPN) Return on Capital Employed Growth (1y) (2013 - 2025) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | ROCE Growth (1y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 87.22 Bn | 85.35 Bn | - | - |
| 2 | Teva Pharmaceutical Industries | 39.60 Bn | 35.87 Bn | 1.97 Bn | 696.00 |
| 3 | Zoetis | 31.46 Bn | 29.52 Bn | 1.62 Bn | -507.00 |
| 4 | Takeda Pharmaceutical | 26.49 Bn | 22.44 Bn | 4.39 Bn | -723.00 |
| 5 | United Therapeutics | 23.03 Bn | 20.88 Bn | 648.10 Mn | 89.00 |
| 6 | Universe Pharmaceuticals | 23.03 Bn | -10.56 Bn | - | - |
| 7 | Viatris | 20.90 Bn | 19.09 Bn | 1.16 Bn | 944.00 |
| 8 | Neurocrine Biosciences | 17.50 Bn | 16.19 Bn | 800.70 Mn | 448.00 |
| 9 | Elanco Animal Health | 12.33 Bn | 11.91 Bn | 785.00 Mn | 1,195.00 |
| 10 | Supernus Pharmaceuticals | 2.72 Bn | 2.34 Bn | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | -1,335.00 |
| Sep 30, 2025 | -916.00 |
| Jun 30, 2025 | 329.00 |
| Mar 31, 2025 | 832.00 |
| Dec 31, 2024 | 821.00 |
| Sep 30, 2024 | 271.00 |
| Jun 30, 2024 | 107.00 |
| Mar 31, 2024 | -625.00 |
| Dec 31, 2023 | -510.00 |
| Sep 30, 2023 | 115.00 |
| Jun 30, 2023 | -400.00 |
| Mar 31, 2023 | -56.00 |
| Dec 31, 2022 | -202.00 |
| Sep 30, 2022 | -740.00 |
| Jun 30, 2022 | -607.00 |
| Mar 31, 2022 | -576.00 |
| Dec 31, 2021 | -681.00 |
| Sep 30, 2021 | -2,712.00 |
| Mar 31, 2021 | -394.00 |
| Dec 31, 2020 | -188.00 |